PTGS2 and neoplasm: Additionally, metformin inhibited inflammatory macrophage infiltration by downregulating both COX2 and PGE2 in tumor cells, suggesting that metformin suppresses prostate cancer by altering tumor TAM infiltration (Liu et al., 2018).